Intravenous (IV) hydration therapy involves providing fluids such as saline, glucose, vitamins and minerals directly into the veins. It is aimed at preventing and treating dehydration. IV hydration therapy is commonly used for hangovers, jet lag, illness or fluid loss due to physical exertion. The therapy replenishes fluid and electrolytes that are depleted from the body quickly and easily when taken intravenously compared to oral rehydration. IV fluids contain everything the body needs during times of illness-induced fluid loss or following exercise/athletic activities.
The global Europe IV Hydration Therapy Market is estimated to be valued at US$ 261.68 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Key Trends:
The key trend fueling the growth of Europe IV hydration therapy market size is increasing demand for preventing dehydration. Dehydration occurs when the body does not have as much water and fluids as it needs. It is caused by excessive fluid loss due to vomiting, diarrhea, excessive sweating, insufficient fluid intake or a combination of these factors. IV hydration therapy provides fluids directly into veins which help prevent and treat dehydration quickly. This avoids long term health issues associated with dehydration such as headaches, dizziness, constipation and in severe cases seizures and kidney problems. Thus, rising awareness about importance of preventing dehydration is driving growth of IV hydration therapy in European countries.
SWOT Analysis
Strength: Europe IV hydration therapy market has strong prevalence of lifestyle diseases like diabetes and obesity which raises the demand for therapeutic IV hydration services. Advancements in IV fluid therapy have widened the scope and adoption of IV hydration therapy.
Weakness: High costs associated with IV therapy treatment limits widespread adoption of IV hydration services. Strict regulations pertaining to aseptic techniques and safety of IV therapy poses challenges.
Opportunity: Rising health consciousness and demand for quick recovery boosts opportunities for ambulatory IV hydration clinics. Growing geriatric population prone to dehydration expands market outlook.
Threats: Alternative oral rehydration solutions limit complete reliance on IV mode of treatment. Risk of contamination and infection is a challenge.
Key Takeaways
The Europe IV hydration therapy market is expected to witness high growth driven by advancements in mobile IV therapy services and rising cases of chronic dehydration. The global Europe IV Hydration Therapy Market is estimated to be valued at US$ 261.68 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.
Regional analysis comprises Western Europe dominates the Europe IV hydration therapy market attributed to high disposable incomes, growing geriatric populace and well-established healthcare infrastructure in countries like Germany, United Kingdom and France.
Key players operating in the Europe IV hydration therapy market are Hydration Room, The IV Doc, AQUAXP, myIVformula, VitaVive Nutraceuticals, Pharmapacks UK Ltd, Hydr8, Amino, Steripack, Nutramax Laboratories, Helios Clinics UK Ltd.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
